BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20976000)

  • 41. Stress Management, Depression and Immune Status in Lower Income Racial/Ethnic Minority Women Co-infected with HIV and HPV.
    Lopez CR; Antoni MH; Pereira D; Seay J; Whitehead N; Potter J; O'Sullivan M; Fletcher MA
    J Appl Biobehav Res; 2013 Mar; 18(1):37-57. PubMed ID: 23526866
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of inflammatory pathways in cancer and infectious disease of the cervix.
    Adefuye A; Sales K
    Scientifica (Cairo); 2012; 2012():548150. PubMed ID: 24278714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preliminary Xpert® HPV testing results from a large study of women living with HIV in Rwanda.
    Murenzi G
    J Virus Erad; 2019 Mar; 5(Suppl 1):6-7. PubMed ID: 30997145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protozoan co-infections and parasite influence on the efficacy of vaccines against bacterial and viral pathogens.
    Akoolo L; Rocha SC; Parveen N
    Front Microbiol; 2022; 13():1020029. PubMed ID: 36504775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women.
    Kuguyo O; Dube Mandishora RS; Thomford NE; Makunike-Mutasa R; Nhachi CFB; Matimba A; Dandara C
    PLoS One; 2021; 16(9):e0257324. PubMed ID: 34582476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and Risk Factors of Infection with High Risk Human Papilloma Viruses among HIV-Positive Women with Clinical Manifestations of Tuberculosis in a Middle-Income Country.
    Isaguliants M; Nosik M; Karlsen A; Petrakova N; Enaeva M; Lebedeva N; Podchufarova D; Laga V; Gromov K; Nazarov A; Chowdhury S; Sinitsyn M; Sobkin A; Chistyakova N; Aleshina S; Grabarnik A; Palefsky JM
    Biomedicines; 2021 Jun; 9(6):. PubMed ID: 34208764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of malaria/helminthic coinfections on cervical cancer progression among sub Saharan African women on highly active antiretroviral therapy: A scoping review.
    Menon S; Rodolfo R; Akudibillah G; Dusabimana A; Harmon S; Mabeya H
    Gynecol Oncol Rep; 2019 Aug; 29():64-69. PubMed ID: 31360742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV.
    Kremer WW; van Zummeren M; Heideman DAM; Lissenberg-Witte BI; Snijders PJF; Steenbergen RDM; Dreyer G; Meijer CJLM
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30360578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clearance of Type-Specific, Low-Risk, and High-Risk Cervical Human Papillomavirus Infections in HIV-Negative and HIV-Positive Women.
    Adebamowo SN; Famooto A; Dareng EO; Olawande O; Olaniyan O; Offiong R; Adebamowo CA
    J Glob Oncol; 2018 Jul; 4():1-12. PubMed ID: 30125130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protocol for the study of cervical cancer screening technologies in HIV-infected women living in Rwanda.
    Murenzi G; Dusingize JC; Rurangwa T; Sinayobye JD; Munyaneza A; Murangwa A; Zawadi T; Hebert T; Mugenzi P; Adedimeji A; Mutesa L; Anastos K; Castle PE
    BMJ Open; 2018 Aug; 8(8):e020432. PubMed ID: 30082342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis.
    Patel P; Rose CE; Collins PY; Nuche-Berenguer B; Sahasrabuddhe VV; Peprah E; Vorkoper S; Pastakia SD; Rausch D; Levitt NS;
    AIDS; 2018 Jul; 32 Suppl 1(Suppl 1):S5-S20. PubMed ID: 29952786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
    Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
    Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Associations between highly active antiretroviral therapy and the presence of HPV, premalignant and malignant cervical lesions in sub-Saharan Africa, a systematic review: current evidence and directions for future research.
    Menon S; Rossi R; Zdraveska N; Kariisa M; Acharya SD; Vanden Broeck D; Callens S
    BMJ Open; 2017 Aug; 7(8):e015123. PubMed ID: 28780541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer.
    Clifford GM; Tully S; Franceschi S
    Clin Infect Dis; 2017 May; 64(9):1228-1235. PubMed ID: 28199532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and predictors of Pap smear cervical epithelial cell abnormality among HIV-positive and negative women attending gynecological examination in cervical cancer screening center at Debre Markos referral hospital, East Gojjam, Northwest Ethiopia.
    Getinet M; Gelaw B; Sisay A; Mahmoud EA; Assefa A
    BMC Clin Pathol; 2015; 15():16. PubMed ID: 26401120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors for cervical intraepithelial neoplasia in HIV-infected women on antiretroviral treatment in Côte d'Ivoire, West Africa.
    Jaquet A; Horo A; Ekouevi DK; Toure B; Coffie PA; Effi B; Lenaud S; Messou E; Minga A; Sasco AJ; Dabis F;
    PLoS One; 2014; 9(3):e90625. PubMed ID: 24595037
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are the currently existing anti-human papillomavirus vaccines appropriate for the developing world?
    van Bogaert Lj
    Ann Med Health Sci Res; 2013 Jul; 3(3):306-12. PubMed ID: 24116304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low Papanicolaou smear screening rate of women with HIV infection: a nationwide population-based study in Taiwan, 2000-2010.
    Chen YC; Liu HY; Li CY; Lee NY; Ko WC; Chou CY; Hsieh TH; Ko NY
    J Womens Health (Larchmt); 2013 Dec; 22(12):1016-22. PubMed ID: 23992102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cervical cancer risk factors among HIV-infected Nigerian women.
    Ononogbu U; Almujtaba M; Modibbo F; Lawal I; Offiong R; Olaniyan O; Dakum P; Spiegelman D; Blattner W; Adebamowo C
    BMC Public Health; 2013 Jun; 13():582. PubMed ID: 23767681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data.
    Mbulaiteye SM; Bhatia K; Adebamowo C; Sasco AJ
    Infect Agent Cancer; 2011 Oct; 6(1):16. PubMed ID: 22004990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.